Cardiovascular toxicity of the antimalarial drugs
In collaboration with WWARN and in association with WHO an extensive review of antimalarial toxicity has been completed, focussing on DHA-piperaquine initially (and showing safety), and now extending to other antimalarial drugs.
The effects of malaria and fever on the ECG have been characterised and approaches for rate correction for the QT interval assessed based on the largest available databases.